Mirae Asset Global Etfs Holdings Ltd. Ionis Pharmaceuticals Inc Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 7,071 shares of IONS stock, worth $488,959. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,071
Previous 8,206
13.83%
Holding current value
$488,959
Previous $247,000
12.96%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding IONS
# of Institutions
413Shares Held
149MCall Options Held
1.72MPut Options Held
722K-
Vanguard Group Inc Valley Forge, PA16.7MShares$1.16 Billion0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16MShares$1.11 Billion0.4% of portfolio
-
Capital World Investors Los Angeles, CA12.5MShares$867 Million0.08% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$714 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.85MShares$543 Million7.06% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $9.82B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...